R3ta (LY3437943) is an investigational, once-weekly peptide being developed by Eli Lilly. Unlike medications that target only GLP-1, retatrutide activates three metabolic hormone receptors: GIP + GLP-1 + glucagon. (Lilly⁠) 🔥 THE 3 PATHWAYS GLP-1 — influences appetite, satiety, gastric emptyi

KLOW is a research blend commonly combining KPV + GHK-Cu + BPC-157 + TB-500, bringing together four peptides studied for different pathways associated with inflammation, tissue remodeling, recovery, and skin biology. 🔬 What’s inside? KPV — Studied for inflammatory and immune-signaling pathway

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper-binding peptide found in the human body. Levels tend to decline with age, and the peptide has attracted significant research interest in skin biology, wound repair, and tissue remodeling. 🔬 Areas of GHK-Cu research includ

The “Wolverine Protocol” is a popular research-peptide combination pairing BPC-157 with TB-500, two peptides studied in preclinical research for pathways involved in tissue repair and recovery. 🔬 BPC-157 Research • Tendon and ligament healing models • Angiogenesis and tissue-repair signaling

🧬 KPV — Small Peptide. Big Research Interest. KPV is a short peptide made up of just 3 amino acids: Lysine–Proline–Valine. It is a naturally occurring fragment of α-MSH (alpha-melanocyte-stimulating hormone) and is being studied for its potential role in regulating inflammatory signaling. 🔬 A

What is GLOW? ✨ GLOW is a popular research peptide blend featuring: 💙 GHK-Cu — a copper peptide studied for skin, collagen, hair & tissue-support pathways 🧬 BPC-157 — researched for tissue repair and recovery pathways ⚡ TB-500 — studied for cellular migration, tissue recovery & heal